Pain Associated With Endometriosis

Lumara Health, Inc.66 enrolled

Overview

This study will evaluate the efficacy and safety of an investigational medication compared with placebo in the treatment of pain associated with endometriosis.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Endometriosis

Interventions

Danazol Once WeeklyDRUG

semi-solid

Danazol Twice WeeklyDRUG

semi-solid

Placebo Once WeeklyDRUG

semi-solid

Placebo Twice Weekly

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Menstruating female 18-50 years of age, * Regular cycle length of 21 to 35 days with menstrual bleeding that typically lasts no more than 7 days, * Has pain associated with endometriosis, * Has a documented history consistent with endometriosis, Exclusion Criteria: * Is pregnant or lactating, * Has a history of or has active thrombosis

Locations (49)

Outcomes

Primary Outcomes

Pain associated with endometriosis

Time frame: 3 months of treatment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Unnamed facility

Chandler, Arizona, United States

Unnamed facility

Phoenix, Arizona, United States

Unnamed facility

Phoenix, Arizona, United States

Unnamed facility

Little Rock, Arkansas, United States

Unnamed facility

Carmichael, California, United States

Unnamed facility

San Diego, California, United States

Unnamed facility

San Diego, California, United States

Unnamed facility

San Diego, California, United States

Unnamed facility

Denver, Colorado, United States

Unnamed facility

Britain, Connecticut, United States

...and 39 more locations